R. Becher

4.0k total citations · 1 hit paper
103 papers, 3.1k citations indexed

About

R. Becher is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, R. Becher has authored 103 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 34 papers in Molecular Biology and 29 papers in Oncology. Recurrent topics in R. Becher's work include Chronic Myeloid Leukemia Treatments (23 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (20 papers). R. Becher is often cited by papers focused on Chronic Myeloid Leukemia Treatments (23 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (20 papers). R. Becher collaborates with scholars based in Germany, United States and Switzerland. R. Becher's co-authors include Zenon Gibas, Vincent P. Stanton, Julian Borrow, Ian D. Dubé, David E. Housman, A.A. Sandberg, Oliver G. Ottmann, Arnold Ganser, Avery A. Sandberg and Frederick G. Behm and has published in prestigious journals such as Nature Genetics, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

R. Becher

99 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein

1996 603 citations Julian Borrow, Vincent P. Stanton et al. Nature Genetics profile →

Peers

Countries citing papers authored by R. Becher

Since Specialization

Citations

This map shows the geographic impact of R. Becher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Becher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Becher more than expected).

Fields of papers citing papers by R. Becher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Becher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Becher. The network helps show where R. Becher may publish in the future.

Co-authorship network of co-authors of R. Becher

This figure shows the co-authorship network connecting the top 25 collaborators of R. Becher. A scholar is included among the top collaborators of R. Becher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Becher. R. Becher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial 1999 ·Breast Cancer Research and Treatment ·O. Kloke, U. Klaassen, C. Oberhoff, (unknown), J. Szántó, (unknown), Markus Heckmann, (unknown), (unknown), (unknown), (unknown), (unknown), R. Rudolph, Andrew E. Berke, (unknown), (unknown), H. Hirche, A. E. Schindler, S. Seeber, R. Becher	31
2	Use of fluorescence in situ hybridization and comparative genomic hybridization in the cytogenetic analysis of testicular germ cell tumors and uveal melanomas 1997 ·Cancer Genetics and Cytogenetics ·R. Becher, W. Michael Korn, Gabriele Prescher	27
3	Prognostic impact of interferon alpha‐induced cytogenetic remission in chronic myelogenous leukaemia: long‐term follow‐up 1996 ·European Journal Of Haematology ·O. Kloke, N. Niederle, Bertram Opalka, (unknown), S. Seeber, R. Becher	7
4	Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer 1996 ·Annals of Oncology ·Hans‐Joachim Wilke, U. Klaassen, W. Achterrath, (unknown), U. Vanhoefer, (unknown), A. Harstrick, Michael Ståhl, Wilfried Eberhardt, R. Becher, S. Seeber	14
5	The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9 1996 ·Nature Genetics ·Julian Borrow, Amanda M. Shearman, Vincent P. Stanton, R. Becher, Tucker Collins, Amy J. Williams, Ian D. Dubé, F Katz, Yok‐Lam Kwong, Christine M. Morris, Kazuma Ohyashiki, Keisuke Toyama, Janet D. Rowley, David E. Housman	372
6	4′-lodo-4′-Deoxydoxorubicin (IDX) in Colorectal Cancer – A Multicenter Phase II Study 1995 ·Oncology Research and Treatment ·Richard Herrmann, K. Mross, Ulrich R. Kleeberg, E.D. Kreuser, R. Becher, Lutz Edler, W. Queißer, P. Liati, S. Kerpel‐Fronius	1
7	Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo 1993 ·Annals of Hematology ·Torsten Haferlach, W. Gaßmann, H. Löffler, Christian Jürgensen, (unknown), Wolfgang Ludwig, E. Thiel, Dagmar Haase, Christa Fonatsch, R. Becher, Brigitte Schlegelberger, M. R. Nowrousian, Eva Lengfelder, Hartmut Eimermacher, (unknown), D. Braumann, Georg Maschmeyer, P. Koch, Achim Heinecke, M. C. Sauerland, (unknown)	22
8	Analysis of the p53 gene in patients with isochromosome 17q and Ph1-positive or -negative myeloid leukemia 1993 ·Leukemia Research ·J. Schütte, Bertram Opalka, R. Becher, Walter Bardenheuer, (unknown), Andreas Lux, S. Seeber	22
9	Phase II Study of Vinorelbine by Oral Route (in a Hard Gelatine Capsule) for Metastatic Breast Cancer Patients 1991 ·Oncology Research and Treatment ·W. Queißer, (unknown), (unknown), K. Bremer, R. Becher, (unknown), F.M. Delgado, Lutz Edler	6
10	Translocation (8;21) in acute nonlymphocytic leukemia delineated by chromosomal in situ suppression hybridization 1991 ·Cancer Genetics and Cytogenetics ·Susanne Popp, Anna Jauch, (unknown), (unknown), Thomas Cremer, R. Becher	8
11	Seven variants including four new Philadelphia translocations 1990 ·Cancer Genetics and Cytogenetics ·R. Becher, (unknown), (unknown), (unknown), (unknown)	2
12	High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen 1989 ·Cancer ·R. Becher, Antonius A. Miller, K. Höffken, (unknown), H. Hirche, Carl G. Schmidt	11
13	Acute myelofibrosis in megakaryoblastic leukemia with translocation between chromosomes 8 and 14 1988 ·Journal of Molecular Medicine ·R. Becher	1
14	5-Fluorouracil and 5-Formyltetrahydrofolate in Advanced Malignancies 1988 ·Advances in experimental medicine and biology ·R. Becher, E. Kurschel, (unknown), O. Kloke, M. E. Scheulen, (unknown), K. Höffken, N. Niederle, (unknown), (unknown), W. Sauerwein, U. Rüther, Carl G. Schmidt	2
15	Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life 1987 ·European Journal of Cancer and Clinical Oncology ·Dietrich W. Beelen, K. Quabeck, Hossam K. Mahmoud, U. W. Schaefer, R. Becher, Carl G. Schmidt, Michael Bamberg, Ulrich Quast, Hans Grosse‐Wilde, E. Haralambie, (unknown), B. Stollmann, (unknown), (unknown), (unknown), (unknown), (unknown)	10
16	Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis. 1986 ·The Journal of Experimental Medicine ·Claus R. Bartram, Johannes W.G. Janssen, R. Becher, Annelies de Klein, Gerard C. Grosveld	33
17	Transplantation of bone marrow with constitutional chromosomal anomalies 1986 ·Annals of Hematology ·R. Becher, Hossam K. Mahmoud, U. W. Schaefer, Carl G. Schmidt	4
18	Marrow transplantation for pancytopenia in dyskeratosis congenita 1985 ·Annals of Hematology ·(unknown), U. W. Schaefer, C. G. Schmidt, R. Becher, (unknown), (unknown)	15
19	Clonal evolution with isodicentric Ph1 chromosome in Ph1-positive CML: Karyotypic conversion after bone marrow transplantation 1984 ·Annals of Hematology ·R. Becher, (unknown), U. W. Schaefer, (unknown), (unknown), (unknown), (unknown), C. G. Schmidt	8
20	Post-rest adaptation of electrical and mechanical activity in the isolated guinea-pig papillary muscle 1982 ·Archives Internationales de Physiologie et de Biochimie ·R. Becher, Ursula Ravens	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact